Germ cell tumor classification: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) No edit summary |
Hudakarman (talk | contribs) No edit summary |
||
Line 118: | Line 118: | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Histopathology}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Histopathology}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Lab finding }} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Lab finding }} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Prognosis}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Prognosis}} | ||
|- | |- | ||
Line 139: | Line 138: | ||
* Hypo- to isointense on T2-weighted images and inhomogenous enhancement on contrast enhanced T1-weighted images. | * Hypo- to isointense on T2-weighted images and inhomogenous enhancement on contrast enhanced T1-weighted images. | ||
* Other diagnostic studies for seminoma include [[biopsy]], [[PET|FDG-PET scan]], and [[bone scan]]. | * Other diagnostic studies for seminoma include [[biopsy]], [[PET|FDG-PET scan]], and [[bone scan]]. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*[[Prognosis]] of [[seminoma]] is good for all stages with greater than 90% cure rate. | *[[Prognosis]] of [[seminoma]] is good for all stages with greater than 90% cure rate. | ||
Line 186: | Line 183: | ||
<br /> | <br /> | ||
|- | |- | ||
| rowspan="6;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Germinomatous/ | | rowspan="6;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Germinomatous/ | ||
Line 193: | Line 188: | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Embryonic | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Embryonic | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 227: | Line 221: | ||
* For malignant teratomas, usually, surgery is followed by chemotherapy. | * For malignant teratomas, usually, surgery is followed by chemotherapy. | ||
* Teratomas that are in surgically inaccessible locations, or are very complex, or are likely to be malignant (due to late discovery and/or treatment) sometimes are treated first with chemotherapy. | * Teratomas that are in surgically inaccessible locations, or are very complex, or are likely to be malignant (due to late discovery and/or treatment) sometimes are treated first with chemotherapy. | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | | ||
Extraembryonic | Extraembryonic | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 299: | Line 283: | ||
<br /> | <br /> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
Line 308: | Line 291: | ||
* On microscopic [[pathology]] | * On microscopic [[pathology]] | ||
* Presence of Schiller-Duval bodies ([[yolk sac tumor]]) | * Presence of Schiller-Duval bodies ([[yolk sac tumor]]) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | |
Revision as of 14:45, 16 September 2019
Germ cell tumors can be classified based on their histologic features into:
Germ cell tumors | |||||||||||||||||||||||||||||||||||||||||||||||
Germinomatous/Undifferentiated/Immature | Nongerminomatous/Differentiated/Embryonal | ||||||||||||||||||||||||||||||||||||||||||||||
Dysgerminoma(Ovary) | Seminoma(Testis) | ||||||||||||||||||||||||||||||||||||||||||||||
Embryonal carcinoma | embryonic tissue | Extraembryonic tissue | |||||||||||||||||||||||||||||||||||||||||||||
Teratoma | |||||||||||||||||||||||||||||||||||||||||||||||
Yolk sac tumor | Choriocarcinoma | ||||||||||||||||||||||||||||||||||||||||||||||
Germ cell tumors | |||||||||||||||||||||||||||||||||||||||||||||||||
Germinomatous/Undifferentiated/Immature | Nongerminomatous/Differentiated/Embryonal | ||||||||||||||||||||||||||||||||||||||||||||||||
Dysgerminoma(Ovary) | Seminoma(Testis) | ||||||||||||||||||||||||||||||||||||||||||||||||
Embryonal carcinoma | embryonic tissue | Extraembryonic tissue | |||||||||||||||||||||||||||||||||||||||||||||||
Teratoma | Yolk sac tumor | Choriocarcinoma | |||||||||||||||||||||||||||||||||||||||||||||||
Germ cell tumors classification is based on the histologic features and whether they are differentiated or not into:
- Germinomatous tumors: (non-differentiated): Gonadal and Extra-gonadal
- Germinoma ( Gonadal: dysgerminoma and seminoma), (Extra-gonadal: mediastinum, or pineal region)
- Dysgerminoma (Ovary)
- Seminoma (testes)
- Nongerminomatous tumors: all other germ-cell tumors, pure and mixed
- Embryonal carcinoma
- Endodermal sinus tumor, also known as yolk sac tumor (EST, YST)
- Choriocarcinoma
- Teratoma including mature teratoma, dermoid cyst, immature teratoma, teratoma with malignant transformation
- Polyembryoma
- Gonadoblastoma
- Mixed germ cell tumors:
Germ cell tumors can also be classified based on their location into:
- Gonadal (ovary and testes)
- Extra-gonadal (MC:mediastinum, retroperitoneal. Less common: Pineal gland, sacrococcigeal)
- Ovarian germ cell tumors (OGCTs ): The histologic types that arise from the ovary are similar to those arising from the testes of men
- Embryo-like neoplasms
- Teratomas and their subtypes
- Dysgerminomas: The female version of the male seminoma (comprised of immature germ cells)
- Extraembryonic fetal-derived (placenta-like) cell populations
- Yolk sac/primitive placenta forms (epithelial neoplasms differentiate into yolk sac tumors)
- Rare OGCTs
- Pure embryonal carcinomas
- Nongestational choriocarcinomas
- Pure polyembryoma.
- Mixed germ cell tumors (teratoma with yolk sac, dysgerminoma, and/or embryonal carcinoma)
- Embryo-like neoplasms
- Extragonadal germ cell tumors (GCTs): no evidence of a primary tumor in the testes or ovaries
- Typically arise in midline locations,
- Specific sites vary with age
- The most common sites in order of frequency
- In adults:
- Anterior mediastinum
- Mature teratomas
- Immature teratoma
- Mediastinal seminoma
- Mediastinal non-seminomatous GCT:
- Yolk sac tumor (most common, pure or mixed)
- Choriocarcinoma (less common)
- Embryonal carcinoma (infrequent)
- Mixed GCTs (a mixture of teratoma, seminoma, and other cell types)
- Retroperitoneum
- Retroperitoneal seminoma
- Retroperitoneal non-seminomatous GCTs (Embryonal carcinoma is common)
- Retroperitoneal teratomas (rare)
- Pineal and suprasellar regions
- Anterior mediastinum
- In infants and young children:
- Sacrococcygeal
- Intracranial GCTs
Types | Subtypes | Signs and Symptoms | Histopathology | Lab finding | Prognosis |
---|---|---|---|---|---|
Germinomatous
/Undifferentiated
|
Seminoma (Testis) |
|
Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface |
|
|
Dysgerminoma (Ovary) |
|
|
|
** Dysgerminoma is radiosensitive. ** Radiotherapy is not anymore the first option of treatment for dysgerminoma considering its association with ovarian failuredevelopment.
| |
Germinomatous/
Differentiated |
Embryonic |
| |||
Teratoma |
|
|
|
| |
Extraembryonic |
|||||
Early Symptoms:
Rare Symptoms:
Late Symptoms
|
Gross pathological:
|
Human chorionic gonadotropin (HCG or b-HCG) is the most common tumor marker test used to diagnose GTD[5]
|
|||
|
References
- ↑
- ↑ Signs and symptoms of gestational trophoblastic disease. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/gestational-trophoblastic-disease/signs-and-symptoms/?region=ns Accessed on October 10, 2015
- ↑ Ober, William B.; Edgcomb, John H.; Price, Edward B. (1971). "THE PATHOLOGY OF CHORIOCARCINOMA". Annals of the New York Academy of Sciences. 172 (10 Physiology a): 299–426. doi:10.1111/j.1749-6632.1971.tb34943.x. ISSN 0077-8923.
- ↑ Smith, Harriet O.; Kohorn, Ernest; Cole, Laurence A. (2005). "Choriocarcinoma and Gestational Trophoblastic Disease". Obstetrics and Gynecology Clinics of North America. 32 (4): 661–684. doi:10.1016/j.ogc.2005.08.001. ISSN 0889-8545.
- ↑ Diagnosing gestational trophoblastic disease. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/gestational-trophoblastic-disease/diagnosis/?region=ns Accessed on October 13, 2015